Personalized mRNA cancer vaccines face hurdles after melanoma Phase 3 success
AI Summary- Intismeran Autogene is being tested in a personalized mRNA lung cancer vaccine trial.
- Three to six weeks are currently needed for each patient’s customized vaccine pipeline.
- Asan Medical Center completed South Korean enrollment in an approximately 900-patient lung cancer trial.